Infinity To Present At 37th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 3, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the 37^th Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2019, at 9:30 a.m. PST (12:30 p.m. EST) in San Francisco, CA. A live webcast of Infinity's presentation will be accessible on the Investors/Media section of Infinity's website at , and will be available for 30 days following the event.

About Infinity
Infinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at .

Contact:
Stephanie Ascher, Stern Investor Relations, Inc.
212-362-1200 or

View original content:

SOURCE Infinity Pharmaceuticals, Inc.